ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.570
-0.020 (-1.26%)
Jun 11, 2026, 3:58 PM CET
STO:EXPRS2 Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -36.24 | -38.09 | -36.04 | -91.4 | -118.61 | -43.93 |
Depreciation & Amortization | 1.38 | 1.47 | 1.64 | 1.6 | 1.25 | 1.5 |
Other Operating Activities | 1.46 | 2.86 | -23.77 | -2.39 | 3.33 | 9.12 |
Change in Accounts Receivable | -8.04 | 0.97 | -2.05 | 8.63 | -8.19 | -1.35 |
Change in Other Net Operating Assets | -4.6 | -8.12 | 26.29 | -17.32 | 22.6 | -10.99 |
Operating Cash Flow | -46.05 | -40.9 | -33.93 | -100.89 | -99.61 | -45.65 |
Capital Expenditures | - | - | -0.87 | -2.02 | -0.38 | -0.72 |
Sale (Purchase) of Intangibles | - | - | - | - | - | 0.05 |
Investment in Securities | - | - | 22.15 | - | - | 0.68 |
Other Investing Activities | - | - | - | - | 105.71 | -100.93 |
Investing Cash Flow | - | - | 21.28 | -2.02 | 105.33 | -100.92 |
Long-Term Debt Issued | - | - | - | 1.47 | - | - |
Total Debt Issued | - | - | - | 1.47 | - | - |
Short-Term Debt Repaid | - | - | - | - | -1.79 | -1.36 |
Long-Term Debt Repaid | - | -0.48 | -0.12 | -3.86 | -0.52 | -0.62 |
Total Debt Repaid | -0.62 | -0.48 | -0.12 | -3.86 | -2.32 | -1.98 |
Net Debt Issued (Repaid) | -0.62 | -0.48 | -0.12 | -2.4 | -2.32 | -1.98 |
Issuance of Common Stock | 12.1 | 12.1 | 42.34 | 60.72 | 75.96 | 83.3 |
Other Financing Activities | -0.84 | -0.84 | -7.35 | -10.48 | -12.19 | -6.78 |
Financing Cash Flow | 10.64 | 10.78 | 34.87 | 47.84 | 61.46 | 74.55 |
Foreign Exchange Rate Adjustments | -0.75 | -3.86 | 1.73 | 1.69 | 6.69 | 2.3 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | -36.16 | -33.99 | 23.94 | -53.38 | 73.86 | -69.72 |
Free Cash Flow | -46.05 | -40.9 | -34.8 | -102.9 | -100 | -46.36 |
Free Cash Flow Margin | -285.69% | -335.09% | -444.70% | -1169.47% | -1625.97% | -337.66% |
Free Cash Flow Per Share | -13.04 | -11.59 | -20.58 | -89.19 | -113.97 | -63.42 |
Cash Interest Paid | 0.14 | 0.06 | 0.14 | 0.63 | 2.72 | 1.19 |
Cash Income Tax Paid | - | -8.11 | -8.15 | -8.47 | -3.59 | -2.8 |
Levered Free Cash Flow | -38 | -32.77 | -17.96 | -75.61 | -68.69 | -37.71 |
Unlevered Free Cash Flow | -37.97 | -32.49 | -17.51 | -75.3 | -68.15 | -37.71 |
Change in Working Capital | -12.64 | -7.15 | 24.24 | -8.7 | 14.41 | -12.34 |